PH19332A - Substituted 4,5-dihydro-6-(substituted)-phenyl-3(2h)-pyridazinones and 6-(substituted)-phenyl-3(2h)-pyridazinones - Google Patents

Substituted 4,5-dihydro-6-(substituted)-phenyl-3(2h)-pyridazinones and 6-(substituted)-phenyl-3(2h)-pyridazinones

Info

Publication number
PH19332A
PH19332A PH27877A PH27877A PH19332A PH 19332 A PH19332 A PH 19332A PH 27877 A PH27877 A PH 27877A PH 27877 A PH27877 A PH 27877A PH 19332 A PH19332 A PH 19332A
Authority
PH
Philippines
Prior art keywords
substituted
phenyl
pyridazinones
compounds
dihydro
Prior art date
Application number
PH27877A
Other languages
English (en)
Inventor
Ila Sircar
James Arthur Bristol
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/302,181 external-priority patent/US4353905A/en
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of PH19332A publication Critical patent/PH19332A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D521/00Heterocyclic compounds containing unspecified hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PH27877A 1981-09-17 1982-09-15 Substituted 4,5-dihydro-6-(substituted)-phenyl-3(2h)-pyridazinones and 6-(substituted)-phenyl-3(2h)-pyridazinones PH19332A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/302,181 US4353905A (en) 1981-09-17 1981-09-17 Substituted 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones and 6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones
US40248882A 1982-07-27 1982-07-27
US40797382A 1982-08-13 1982-08-13

Publications (1)

Publication Number Publication Date
PH19332A true PH19332A (en) 1986-03-20

Family

ID=27404868

Family Applications (1)

Application Number Title Priority Date Filing Date
PH27877A PH19332A (en) 1981-09-17 1982-09-15 Substituted 4,5-dihydro-6-(substituted)-phenyl-3(2h)-pyridazinones and 6-(substituted)-phenyl-3(2h)-pyridazinones

Country Status (17)

Country Link
EP (1) EP0075436B1 (fi)
KR (1) KR880001623B1 (fi)
AT (1) ATE18909T1 (fi)
AU (1) AU563448B2 (fi)
CA (1) CA1190548A (fi)
DD (1) DD208615A5 (fi)
DE (1) DE3270274D1 (fi)
DK (1) DK414482A (fi)
ES (1) ES8400414A1 (fi)
FI (1) FI76084C (fi)
GR (1) GR76999B (fi)
HU (1) HU190412B (fi)
IE (1) IE54101B1 (fi)
IL (1) IL66815A (fi)
NO (1) NO159595C (fi)
NZ (1) NZ201929A (fi)
PH (1) PH19332A (fi)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3212304A1 (de) * 1982-04-02 1983-10-06 Nattermann A & Cie Imidazolylphenyl-tetrahydropyridazine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3241102A1 (de) * 1982-11-06 1984-05-10 A. Nattermann & Cie GmbH, 5000 Köln Imidazolylalkylthienyl-tetrahydropyridazine und verfahren zu ihrer herstellung
GB8310435D0 (en) * 1983-04-18 1983-05-25 Fujisawa Pharmaceutical Co Triazine derivatives
DE3321012A1 (de) * 1983-06-10 1984-12-13 A. Nattermann & Cie GmbH, 5000 Köln Substituierte 4,5-dihydro-6-(thien-2-yl)-3(2h)-pyridazinone und 6-(thien-2-yl)-3(2h)-pyridazinone sowie verfahren zu ihrer herstellung
US4599332A (en) * 1983-12-07 1986-07-08 Warner-Lambert Company 4,5-dihydro-6-[2-[4-(1H-imidazol-1-yl)phenyl]-ethenyl]-3(2H)-pyridazinones and related compounds
DE3401911A1 (de) * 1984-01-20 1985-08-01 A. Nattermann & Cie GmbH, 5000 Köln Substituierte 4,5-dihydro-6-vinyl-3(2h)-pyridazinone und 6-vinyl-3(2h)-pyridazinone sowie verfahren zu ihrer herstellung
DE3407509A1 (de) * 1984-03-01 1985-09-05 A. Nattermann & Cie GmbH, 5000 Köln Neue arzneimittelkombination zur behandlung von bluthochdruck und thromboembolischen erkrankungen
US4584299A (en) * 1984-05-21 1986-04-22 Warner-Lambert Company Method of treating heart failure and medicaments therefor
DE3425632A1 (de) * 1984-07-12 1986-01-16 Basf Ag, 6700 Ludwigshafen (pyrrol-1-yl)-phenyl-dihydropyridazinone, ihre herstellung und verwendung
JPS61158969A (ja) * 1984-12-24 1986-07-18 ワーナー‐ランバート・コンパニー 4,5‐ジヒドロ‐4,4‐ジアルキル‐6‐(置換)フエニル‐3(2h)‐ピリダジノン類
GB8502267D0 (en) * 1985-01-30 1985-02-27 Pfizer Ltd Quinolone inotropic agents
IL79280A (en) * 1985-07-05 1990-07-12 Smith Kline French Lab 4-(6-oxo-dihydro or tetrahydropyridazin-3-yl)benzene derivatives,their preparation and pharmaceutical compositions containing them
US4783463A (en) * 1985-10-23 1988-11-08 Rorer Pharmaceutical Corporation Pyridyl-pyridazinone and pyridyl-pyrazolinone compounds and their use in the treatment of congestive heart failure
US4826835A (en) * 1985-10-23 1989-05-02 Rorer Pharmaceutical Corporation Pyridyl-pyridazinone and pyridyl-pyrazolinone compounds and their use in the treatment of congestive heart failure
DE3600275A1 (de) * 1986-01-08 1987-07-09 Basf Ag Substituierte pyrrol-1-ylphenyldihydropyridazinone, ihre herstellung und verwendung
DE3626865A1 (de) * 1986-08-08 1988-02-11 Boehringer Mannheim Gmbh Neue pyridazinon-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4888169A (en) * 1986-10-14 1989-12-19 Norden Laboratories, Inc. Bordetella Bronchiseptica vaccine
US4970210A (en) * 1987-07-17 1990-11-13 Abbott Laboratories Triazinone lipoxygenase compounds
ATE110071T1 (de) * 1988-01-23 1994-09-15 Kyowa Hakko Kogyo Kk Pyridazinon-derivate und diese enthaltende pharmazeutische zubereitungen.
DE3804490A1 (de) * 1988-02-12 1989-08-24 Heumann Pharma Gmbh & Co Substituierte 6-phenyldihydro-3(2h)-pyridazinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3814057A1 (de) * 1988-04-26 1989-11-09 Heumann Pharma Gmbh & Co 6-oxo-pyridazinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3826855A1 (de) * 1988-08-06 1990-02-15 Cassella Ag 4,5-dihydro-3(2h)-pyridazinone, verfahren zu ihrer herstellung und ihre verwendung
DE3913597A1 (de) * 1989-04-25 1990-11-08 Heumann Pharma Gmbh & Co Diazinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DK40192D0 (da) * 1992-03-26 1992-03-26 Neurosearch As Imidazolforbindelser, deres fremstilling og anvendelse
US7462613B2 (en) 2002-11-19 2008-12-09 Sanofi-Aventis Deutschland Gmbh Pyridazinone derivatives as pharmaceuticals and pharmaceutical compositions containing them
US7309701B2 (en) 2002-11-19 2007-12-18 Sanofi-Aventis Deutschland Gmbh Pyridazinone derivatives as pharmaceuticals and pharmaceutical compositions containing them
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
EP1598348A1 (en) 2004-05-18 2005-11-23 Aventis Pharma Deutschland GmbH Novel pyridazinone derivatives as inhibitors of CDK2
EP1604988A1 (en) 2004-05-18 2005-12-14 Sanofi-Aventis Deutschland GmbH Pyridazinone derivatives, methods for producing them and their use as pharmaceuticals
TWI375669B (en) 2006-03-17 2012-11-01 Sumitomo Chemical Co Pyridazinone compound and use thereof
EP2069312B1 (en) 2006-07-25 2012-11-07 Cephalon, Inc. Pyridizinone derivatives
JP5546451B2 (ja) 2007-06-04 2014-07-09 シナジー ファーマシューティカルズ インコーポレイテッド 胃腸の障害、炎症、癌および他の障害の処置に有用なグアニル酸シクラーゼのアゴニスト
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
AU2009256157B2 (en) 2008-06-04 2014-12-18 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2010009319A2 (en) 2008-07-16 2010-01-21 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CN103764672A (zh) 2011-03-01 2014-04-30 辛纳吉制药公司 制备鸟苷酸环化酶c激动剂的方法
WO2014131024A2 (en) 2013-02-25 2014-08-28 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
WO2014151206A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
US10011637B2 (en) 2013-06-05 2018-07-03 Synergy Pharmaceuticals, Inc. Ultra-pure agonists of guanylate cyclase C, method of making and using same
US20160184387A1 (en) 2013-08-09 2016-06-30 Dominique Charmot Compounds and methods for inhibiting phosphate transport
WO2020237096A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Combination for lowering serum phosphate in a patient

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1383906A (en) * 1971-02-22 1974-02-12 Bdh Pharmaceuticals Ltd Pyridazinones
BE790106A (fr) * 1971-10-14 1973-04-13 Basf Ag Dihydropyridazones, leur preparation et leurs utilisations therapeutiques
DE3130251A1 (de) * 1981-07-31 1983-02-17 A. Nattermann & Cie GmbH, 5000 Köln 6-(4-((omega)-(1-imidazolyl)-alkyl)-phenyl)-3-oxo -2,3,4,5-tetrahydro-pyridazine und deren saeureadditionssalze, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate

Also Published As

Publication number Publication date
IE822250L (en) 1983-03-17
CA1190548A (en) 1985-07-16
IL66815A0 (en) 1982-12-31
AU8840982A (en) 1983-03-24
FI76084C (fi) 1988-09-09
KR880001623B1 (ko) 1988-09-02
DE3270274D1 (en) 1986-05-07
IE54101B1 (en) 1989-06-21
IL66815A (en) 1986-02-28
NO823128L (no) 1983-03-18
DD208615A5 (de) 1984-04-04
EP0075436A1 (en) 1983-03-30
AU563448B2 (en) 1987-07-09
NZ201929A (en) 1985-11-08
NO159595B (no) 1988-10-10
HU190412B (en) 1986-09-29
ATE18909T1 (de) 1986-04-15
KR840001570A (ko) 1984-05-07
GR76999B (fi) 1984-09-04
FI823184A0 (fi) 1982-09-15
EP0075436B1 (en) 1986-04-02
FI823184L (fi) 1983-03-18
NO159595C (no) 1989-01-18
DK414482A (da) 1983-03-18
ES515743A0 (es) 1983-10-16
FI76084B (fi) 1988-05-31
ES8400414A1 (es) 1983-10-16

Similar Documents

Publication Publication Date Title
DE3270274D1 (en) Substituted 4,5-dihydro-6-(substituted)-phenyl-3(2h)-pyridazinones and 6-(substituted)phenyl-3(2h)-pyridazinones
YU1900A (sh) Derivati ariloksiarilsulfonilamino hidroksaminske kiseline
ES425786A1 (es) Procedimiento para la preparacion de nuevas indolil-piperi-dino-(o 1,2,5,6-tetrahidro-piridil)-butirofenonas.
PL235561A1 (fi)
KR860003232A (ko) 피리다지논 유도체의 제조방법
NO911158L (no) Hydantoinderivater.
MY101042A (en) Pyridazinone derivatives,process for preparation thereof, and insecticidal compotions
ES8600277A1 (es) Un procedimiento para preparar derivados de piridazinona
ES8107215A1 (es) Un procedimiento para preparar una 2-r-6-py-3(2h)-piridaci- nona
DE3572816D1 (de) Pyridazinone inotropic agents
ES8606847A1 (es) Procedimiento para la preparacion de derivados de dialquila-mino-etilanilina antihipertensos
ES8602772A1 (es) Un procedimiento de preparar un derivado de 4,5-dihidro-6-(2-(4-(1h-imidazol-1-il)-fenil)-alquilenil o alquilen-3(2h)-piridazinona.
ES466794A1 (es) Un procedimiento para la preparacion de derivados de imida- zol.
ES8704479A1 (es) Procedimiento para preparar piridazinonas alquil-sustituidas
EP0186484A3 (en) 4,5-dihydro-4,4-dialkyl-6-)substituted) phenyl-3-(2h)-pyridazinones useful as cardiotonic agents
SE8102660L (sv) 6-(pyridinyl)-4-substituerade-3-(2h)-pyridazinoner, anvendbara som kardiotoniska medel, och framstellning derav
ES8601917A1 (es) Procedimiento para producir 4,5-dihidro-6-vinil-3(2h)-piri- dazinonas y 6-vinil-3(2h)-piridazinonas
ES8203880A1 (es) Un procedimiento para preparar una 4,5-dihidro-2-r-4-r -6-py-3(2h)-piridazinona